Skip to main content
SpringerLink
Log in

Germ Cell Tumors

  • Chapter
  • First Online:
Diabetes Insipidus in Children

  • 366 Accesses

Abstract

Germ cell tumors (GCTs) are a rare group of pediatric brain tumors that occur in the midline and often present with endocrinopathies including central diabetes insipidus (DI) or anterior pituitary deficiencies. Symptoms of central DI may be present in patients for months to years prior to definitive diagnosis. Patients may require long-term serial imaging and monitoring of tumor markers to ensure appropriate diagnosis and treatment. Germ cell tumors are subdivided into germinomas and nongerminomatous germ cell tumors (NGGCT) based on histology and tumor markers. Germinomas are quite radiosensitive, and historically have been treated with radiation therapy alone. NGGCTs are less responsive to radiation and require a more aggressive treatment approach with the addition of chemotherapy and sometimes surgery. Due to the complexities of diagnosis and management, these patients require a multidisciplinary approach to management including endocrinology, neurosurgery, neuro-oncology, radiation oncology, and neuro-ophthalmology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zong Z, Wang Y, Dai C, et al. Central nervous system germ cell tumors: a review of the literature. J Child Neurol. 2018;33(9):610–20.

    Article  Google Scholar 

  2. Fujimaki T. Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview. J Child Neurol. 2009;24(11):1439–45.

    Article  Google Scholar 

  3. Phi JH, Wang KC, Kim SK. Intracranial germ cell tumors in the molecular era. J Korean Neurosurg Soc. 2018;61(3):333–42.

    Article  CAS  Google Scholar 

  4. Di Lorgi N, Morana G, Maghnie M. Pituitary Stalk thickening on MRI: when is the best time to re-scan and how long should we continue re-scanning for? Clin Endocrinol. 2015;83:449–55.

    Article  CAS  Google Scholar 

  5. Di Lorgi N, Allegri AE, Napoli F, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab. 2014;99(4):1264–72.

    Article  CAS  Google Scholar 

  6. Corredor Andrés B, Muñoz Calvo MT, López Pino MA, et al. Thickening of pituitary stalk in children and adolescents with central diabetes insipidus: causes and consequences. An Pediatr (Engl Ed). 2019;90(5):293–300.

    Article  Google Scholar 

  7. Leger J, Velasquez A, Garel C, Hassan M, Czernichow P. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metabol. 1999;84(6):1954–60.

    CAS  Google Scholar 

  8. Louis D, Perry A, Reifenerger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.

    Article  Google Scholar 

  9. Bowzky Al-Naeeb A, Murray A, Horan G, et al. Current management of intracranial germ cell tumours. Clin Oncol. 2018;30:204–14.

    Article  Google Scholar 

  10. Murray M, Bartels U, Nishikawa R, et al. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol. 2015;16:470–7.

    Article  Google Scholar 

  11. Robison NJ, Prabhu SP, Sun P, et al. Predictors of neoplastic disease in children with isolated pituitary stalk thickening. Pediatr Blood Cancer. 2013;60:1630–5.

    Article  Google Scholar 

  12. Catford S, Yuen Wang Y, Wong R. Pituitary stalk lesions: systematic review and clinical guidance. Clin Endocrinol. 2016;85:507–21.

    Article  Google Scholar 

  13. Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, et al. Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol. 1999;17(8):2585–92.

    Article  CAS  Google Scholar 

  14. Shirato H, Nishio M, Sawamura Y, et al. Analysis of long-term treatment of intracranial germinoma. Int J Radiat. Oncol Biol Phys. 1997;37(3):511–5.

    Article  CAS  Google Scholar 

  15. Merchant TE, Sherwood SH, Mulhern RK, Rose SR, Thompson SJ, Sanford RA, Kun LE. CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2000;46(5):1171–6.

    Article  CAS  Google Scholar 

  16. Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D’Angio G, Siegel KR, Schut L. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg. 1989;70(5):707–13.

    Article  CAS  Google Scholar 

  17. Balmaceda C, Heller G, Rosenblum M, et al. Chemotherapy without irradiation—a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol. 1996;14:2908–15.

    Article  CAS  Google Scholar 

  18. Calaminus G, Kortmann R-D, Worch J, Nicholson JC, Alapetite C, Garre ML, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro-Oncology. 2013;15:788–96.

    Article  CAS  Google Scholar 

  19. Kellie SJ, Boyce H, Dunkel IJ, et al. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr Blood Cancer. 2004;43(2):126–33.

    Article  Google Scholar 

  20. Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, et al. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro-Oncology. 2010;12(12):1318–25.

    PubMed  PubMed Central  CAS  Google Scholar 

  21. Rogers SJ, Mosleh-Shirazi MA, Saran FH. Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol. 2005;6:509–19.

    Article  CAS  Google Scholar 

  22. Aoyama H, Shirato H, Yoshia H, et al. Retrospective multi-institutional study of radiotherapy for intracranial nongerminomatous germ cell tumors. Radiother Oncol. 1998;49:55–9.

    Article  CAS  Google Scholar 

  23. Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr. 2004;216(3):141–9.

    Article  CAS  Google Scholar 

  24. Goldman S, Bouffet E, Fisher PG, Allen JC, Robertson PL, Chuba PJ, Donahue B, Kretschmar CS, Zhou T, Buxton AB, Pollack IF. Phase II trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors: a children’s Oncology Group Study. J Clin Oncol. 2015;33(22):2464–71.

    Article  CAS  Google Scholar 

  25. Abu Arja MH, Boufett E, Finlay JL, AbdelBaki MS. Critical Review of the management of primary central nervous nongerminomatous germ cell tumors. Pediatr Blood Cancer. 2019;16:e27658.

    Article  Google Scholar 

  26. Kim J, Park J. Understanding the treatment strategies of intracranial germ cell tumors: focusing on radiotherapy. J Korean Neurosurg Soc. 2015;57(5):315–22.

    Article  CAS  Google Scholar 

  27. Fangusaro J, Wu S, MacDonald S, et al. Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: a children’s Oncology Group Study. J Clin Oncol. 2019;37(34):3283–90.

    Article  CAS  Google Scholar 

  28. Liang SY, Yang TF, Chen YW, Liang ML, Chen HH, Chang KP, Shan IK, Chen YS, Wong TT. Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment. Neuro-Oncology. 2013;15(11):1543–51.

    Article  Google Scholar 

  29. Wang L, Yamaguchi S, Burstein M, et al. Novel somatic and germline mutations in intracranial germ cell tumours. Nature. 2014;511(7508):241–5.

    Article  CAS  Google Scholar 

  30. Fukushima S, Otsuka A, Suzuki T, et al. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas. Acta Neuropathol. 2014;127(6):911–25.

    Article  CAS  Google Scholar 

  31. Ichimura K, Fukushima S, Totoki Y, et al. Recurrent neomorphic mutations of MTOR in central nervoussystem and testicular germ cell tumors may be targeted for therapy. Acta Neuropathol. 2016;131(6):889–901.

    Article  CAS  Google Scholar 

  32. Tamaki H, Fukuoka K, Fukushima S, et al. Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium. Neuro-Oncology. 2019;21(12):1565–77.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Kavita Desai & Michael J. Fisher

  2. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

    Kavita Desai & Michael J. Fisher

Authors
  1. Kavita Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kavita Desai .

Editor information

Editors and Affiliations

  1. Division of Endocrinology and Diabetes, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Craig A. Alter

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Desai, K., Fisher, M.J. (2021). Germ Cell Tumors. In: Alter, C.A. (eds) Diabetes Insipidus in Children. Springer, Cham. https://doi.org/10.1007/978-3-030-83248-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-83248-3_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-83247-6

  • Online ISBN: 978-3-030-83248-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation